Last reviewed · How we verify
Valeriana officinalis
At a glance
| Generic name | Valeriana officinalis |
|---|---|
| Also known as | VALERIANE |
| Sponsor | Millet Roux |
| Drug class | Standardized Chemical Allergen [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
- Cold Clammy Feet Relief
- Numbness of Limbs Relief
- Painful Calves Upon Walking Relief
- Muscular Weakness of Lower Extremities Relief
Common side effects
Key clinical trials
- Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B) (NA)
- Chronic Effects of Euphytose® on Psychological and Physiological Measures of Stress (NA)
- (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy (PHASE3)
- Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety (PHASE3)
- Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery (NA)
- Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia (PHASE3)
- Therapeutic Effect of an Herbal Medicine on Anxiety (PHASE3)
- A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Valeriana officinalis CI brief — competitive landscape report
- Valeriana officinalis updates RSS · CI watch RSS
- Millet Roux portfolio CI